Verici Dx (VRCI LN)

Verici Dx is an immuno-diagnostics development company focused on prognostic and diagnostic tests for kidney transplant patients. The company develops a suite of proprietary tests including Clarava, Tuteva, and Protega, utilizing AI-assisted transcriptomic analysis to provide RNA signatures for personalized patient and organ response risk. Verici Dx was founded in 2020 and is headquartered in Cardiff, United Kingdom.